Treatment Action Group (TAG) launches the 2022 Tuberculosis Diagnostics Pipeline Report.
To effectively treat TB, people with TB must first be diagnosed – but last year, only 6.4 million out of 10.6 million people with active TB were diagnosed and notified. This nearly 40 percent gap points to the need for better TB diagnostics and improved access to care.
Treatment Action Group (TAG) released the 2022 Tuberculosis Diagnostics Pipeline Report by TAG TB Project Officer David Branigan. The report details the TB diagnostic technologies currently under development and emphasizes five key research priorities: (1) pediatric TB diagnostics, (2) point-of-care urine LAM tests, (3) non-sputum point-of-care molecular tests for TB and drug-resistant TB, (4) TB screening and triage tools, and (5) algorithms for TB screening and diagnostic testing. Moving forward, increased investment and involvement of affected communities in TB diagnostics research and development will be key to ensuring that everyone at risk of TB benefits from scientific progress and receives the best available care.
The 2022 Tuberculosis Diagnostics Pipeline Report is available here. It is part of a series of Pipeline reports covering TB Vaccines, a forthcoming report on TB Treatment, as well as reports on HIV and long-acting technologies for hepatitis C, opioid use and overdose prevention, and malaria.
For more TB news, check out the latest edition of the TB Online Weekly Newsletter (#38, 16 November 2022).
Source : Treatment Action Group
Related HIV and Co-Infections News
-
[Report] Physicians for Human Rights: Trump administration foreign policy approach to South Africa wastes billions of dollars, imperils global health
-
BMJ Group: Trial assesses safety and effectiveness of two new TB vaccines
-
AVAC: Abrupt shutdown of US global health supply chain raises risks for HIV, TB and malaria programs
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.